{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T04:57:46Z","timestamp":1791262666078,"version":"4.1.0"},"reference-count":24,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2002,4,1]],"date-time":"2002-04-01T00:00:00Z","timestamp":1017619200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2002,4,1]],"date-time":"2002-04-01T00:00:00Z","timestamp":1017619200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2014,2,17]],"date-time":"2014-02-17T00:00:00Z","timestamp":1392595200000},"content-version":"vor","delay-in-days":4340,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","oarsijournal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Osteoarthritis and Cartilage"],"published-print":{"date-parts":[[2002,4]]},"DOI":"10.1053\/joca.2002.0515","type":"journal-article","created":{"date-parts":[[2002,9,19]],"date-time":"2002-09-19T09:56:27Z","timestamp":1032429387000},"page":"264-269","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":17,"title":["Susceptibility to physiological concentrations of IL-1\u03b2 varies in cartilage at different anatomical locations on human osteoarthritic knee joints"],"prefix":"10.1053","volume":"10","author":[{"given":"A.F.","family":"Barakat","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C.J.","family":"Elson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C.I.","family":"Westacott","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1053\/joca.2002.0515_RF1","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1111\/j.2042-7158.1991.tb06668.x","article-title":"Differential responses of human and rat cartilage to degrading stimuli in vitro","volume":"43","author":"Ismaiel","year":"1991","journal-title":"J Pharm Pharmacol"},{"key":"10.1053\/joca.2002.0515_RF2","series-title":"Articular Cartilage and Osteoarthritis","first-page":"251","article-title":"Mediators of matrix catabolism","author":"Tyler","year":"1992"},{"key":"10.1053\/joca.2002.0515_RF3","first-page":"19","article-title":"Evidence for the involvement of interleukin 1 in human osteoarthritic cartilage degradation: protective effect of NSAID","volume":"Suppl 1","author":"Pelletier","year":"1989","journal-title":"J Rheumatol"},{"key":"10.1053\/joca.2002.0515_RF4","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/S1063-4584(05)80026-3","article-title":"Metalloprotease activity, phospholipase A2 activity and cytokine concentration in osteoarthritis synovial fluids","volume":"1","author":"Vignon","year":"1993","journal-title":"Osteoarthritis Cart"},{"key":"10.1053\/joca.2002.0515_RF5","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/S0140-6736(85)90229-6","article-title":"Cartilage proteoglycans in synovial fluid and serum in patients with inflammatory joint disease: relation to systemic treatment","volume":"ii","author":"Saxne","year":"1985","journal-title":"Lancet"},{"key":"10.1053\/joca.2002.0515_RF6","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1172\/JCI113929","article-title":"Immunohistochemical detection and immunochemical analysis of type II collagen degradation in human normal, rheumatoid and osteoarthritic articular cartilage and in explants of bovine articular cartilage cultured with interleukin-1","volume":"83","author":"Dodge","year":"1989","journal-title":"J Clin Invest"},{"key":"10.1053\/joca.2002.0515_RF7","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1136\/ard.49.9.676","article-title":"Synovial fluid concentrations of five different cytokines in rheumatic diseases","volume":"49","author":"Westacott","year":"1990","journal-title":"Annals Rheum Dis"},{"key":"10.1053\/joca.2002.0515_RF8","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1093\/rheumatology\/37.1.106","article-title":"Cytokines and focal loss of cartilage in osteoarthritis","volume":"37","author":"Elson","year":"1998","journal-title":"Br J Rheumatol"},{"key":"10.1053\/joca.2002.0515_RF9","doi-asserted-by":"crossref","first-page":"638","DOI":"10.1136\/ard.51.5.638","article-title":"Interleukin-1\u03b1 and \u03b2 production by cells isolated from the membrane around aseptically loose total joint replacements","volume":"51","author":"Westacott","year":"1992","journal-title":"Ann Rheum Dis"},{"key":"10.1053\/joca.2002.0515_RF10","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1093\/rheumatology\/31.6.369","article-title":"Susceptibility of normal and arthritic human articular cartilage to degradative stimuli","volume":"21","author":"Ismaiel","year":"1992","journal-title":"Br J Rheumatol"},{"key":"10.1053\/joca.2002.0515_RF11","first-page":"739","article-title":"Human articular cartilage degradation and chondrocyte expression of tumour necrosis factor receptors","volume":"8","author":"Westacott","year":"1993","journal-title":"Trans Orthop Res Soc"},{"key":"10.1053\/joca.2002.0515_RF12","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1002\/art.1780350507","article-title":"The interleukin-1 receptor in normal and osteoarthritic human chondrocytes","volume":"35","author":"Martel-Pelletier","year":"1992","journal-title":"Arthritis Rheum"},{"key":"10.1053\/joca.2002.0515_RF13","first-page":"1710","article-title":"Tumor necrosis factor receptor expression on chondrocytes isolated from human articular cartilage","volume":"21","author":"Westacott","year":"1994","journal-title":"J Rheumatol"},{"key":"10.1053\/joca.2002.0515_RF14","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1016\/S1063-4584(97)80047-7","article-title":"Chondrocyte tumor necrosis factor and focal loss of cartilage in OA","volume":"5","author":"Webb","year":"1997","journal-title":"Osteoarthritis Cart"},{"key":"10.1053\/joca.2002.0515_RF15","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1053\/joca.1999.0292","article-title":"Tumor necrosis factor alpha can contribute to focal loss of cartilage in osteoarthritis","volume":"8","author":"Westacott","year":"2000","journal-title":"Osteoarthritis and Cartilage"},{"key":"10.1053\/joca.2002.0515_RF16","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1016\/0304-4165(86)90306-5","article-title":"Improved quantitation and discrimination of sulphatedglycosaminoglycans by use of dimethylmethylene blue","volume":"883","author":"Farndale","year":"1986","journal-title":"Biochem Biophys Acta"},{"key":"10.1053\/joca.2002.0515_RF17","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1053\/joca.1998.0109","article-title":"Osteoarthritic synovial fluids and synovium supernatants up-regulate tumour necrosis factor receptors on human articular cartilage","volume":"6","author":"Webb","year":"1998","journal-title":"Osteoarthritis Cart"},{"key":"10.1053\/joca.2002.0515_RF18","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1002\/art.1780390316","article-title":"The superficial layer of human articular cartilage is more susceptible to interleukin-induced damage than the deeper layers","volume":"39","author":"Hauselmann","year":"1996","journal-title":"Arthritis Rheum"},{"key":"10.1053\/joca.2002.0515_RF19","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1002\/1529-0131(200001)43:1<195::AID-ANR24>3.0.CO;2-G","article-title":"Autocrine regulation of collagenase 3 (matrix metalloproteinase 13) during osteoarthritis","volume":"43","author":"Shlopov","year":"2000","journal-title":"Arthritis Rheum"},{"key":"10.1053\/joca.2002.0515_RF20","doi-asserted-by":"crossref","first-page":"6155","DOI":"10.1073\/pnas.90.13.6155","article-title":"Interleukin-1 signalling occurs exclusively via the type I receptor","volume":"90","author":"Sims","year":"1993","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1053\/joca.2002.0515_RF21","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1002\/jcp.1041380204","article-title":"Induction of interleukin-1 receptors on chondrocytes by fibroblast growth factor: a possible mechanism for modulation of interleukin-1 activity","volume":"138","author":"Chandrasekhar","year":"1989","journal-title":"J Cell Physiol"},{"key":"10.1053\/joca.2002.0515_RF22","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1002\/1529-0131(200103)44:3<585::AID-ANR107>3.0.CO;2-C","article-title":"Matrix metalloproteinase and proinflammatory cytokine production by chondrocytes of human osteoarthritic cartilage","volume":"44","author":"Tetlow","year":"2001","journal-title":"Arthritis Rheum"},{"key":"10.1053\/joca.2002.0515_RF23","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1002\/(SICI)1097-4644(19980915)70:4<517::AID-JCB8>3.0.CO;2-M","article-title":"Up-regulation of tissue inhibitor of metalloproteinases-3 gene expression by TGF-beta in articular chondrocytes is mediated by serin\/threonine and tyrosine kinases","volume":"70","author":"Su","year":"1998","journal-title":"J Cell Biochem"},{"key":"10.1053\/joca.2002.0515_RF24","doi-asserted-by":"crossref","first-page":"12501","DOI":"10.1074\/jbc.C000848200","article-title":"TIMP-3 is a potent inhibitor of aggrecanase-1 (ADAM-TS4) and aggrecanase-2 (ADAM-TS5)","volume":"276","author":"Kashiwagi","year":"2001","journal-title":"J Biol Chem"}],"container-title":["Osteoarthritis and Cartilage"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1063458402905157?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1063458402905157?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T03:00:29Z","timestamp":1761015629000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1063458402905157"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2002,4]]},"references-count":24,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2002,4]]}},"alternative-id":["S1063458402905157"],"URL":"https:\/\/doi.org\/10.1053\/joca.2002.0515","relation":{},"ISSN":["1063-4584"],"issn-type":[{"value":"1063-4584","type":"print"}],"subject":[],"published":{"date-parts":[[2002,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Susceptibility to physiological concentrations of IL-1\u03b2 varies in cartilage at different anatomical locations on human osteoarthritic knee joints","name":"articletitle","label":"Article Title"},{"value":"Osteoarthritis and Cartilage","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1053\/joca.2002.0515","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"converted-article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2002 OsteoArthritis Research Society International. Published by Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}